Tevogen Bio (NASDAQ:TVGNW) Stock Price & Analysis

–

USD

–(–)

Open

$0.045

Prev. Close

$0.0508

High

$0.057

Low

$0.0441

Company Profile

Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.

CEORyan H. Saadi

SectorHealthcare

IndustryBiotechnology

Employees18

IPO DateFeb 15, 2024

ExchangeNASDAQ

Exchange NameNASDAQ Capital Market

CurrencyUSD

Headquarters & Contact

Address15 Independence Blvd

City / State / ZIPWarren, NJ, 07059

CountryUnited States

Phone877 838 6436

Websitehttps://tevogen.com

Tevogen Bio Holdings Inc.

Company Profile

Recently from Cashu